<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01918982</url>
  </required_header>
  <id_info>
    <org_study_id>147/362</org_study_id>
    <nct_id>NCT01918982</nct_id>
  </id_info>
  <brief_title>Circulating Endothelial Progenitor Cells and Aortic Aneurysm</brief_title>
  <acronym>ANOPEC3</acronym>
  <official_title>Interest of Circulating Endothelial Progenitor Cells CD34+144+CD14- and CD34+VEGF-R2+CD14- in the Follow-up of Aortic Aneurysm</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Jean Minjoz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Jean Minjoz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We aimed to see if aortic aneurysms could be followed-up by circulating endothelial
      progenitor cells CD34+144+CD14- and CD34+VEGF-R2+CD14- blood level.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Circulating endothelial progenitor cells CD34+144+CD14- and CD34+VEGF-R2+CD14- have been
      shown to be inversely correlated to aortic aneurysm size. We aimed to see if aortic aneurysms
      could be followed-up by circulating endothelial progenitor cells CD34+144+CD14- and
      CD34+VEGF-R2+CD14- blood level. 40 patients followed for known aortic aneurysm &gt;30mm and
      &lt;50mm will be followed up every 6 months during 2 years. Each 6 months they will have a
      consultation by their physiologist with an echo or a CT-scan. At the same time, a 10ML blood
      sample will be taken to assess the circulating endothelial progenitor cells CD34+144+CD14-
      and CD34+VEGF-R2+CD14- blood level.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">May 2016</completion_date>
  <primary_completion_date type="Anticipated">February 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Circulating endothelial progenitor cells CD34+144+CD14- and CD34+VEGF-R2+CD14- blood concentration</measure>
    <time_frame>2 years</time_frame>
    <description>Patients are followed for 2 years</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>- Aortic Aneurysm</condition>
  <arm_group>
    <arm_group_label>Aortic aneurysm</arm_group_label>
    <description>Patients with aortic aneurysm &gt;30mm and &lt; 50mm</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with aortic aneurysm
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aortic aneurysm size &gt;30mm and &gt; 50mm

        Exclusion Criteria:

          -  Infectious disease

          -  Inflammatory disease

          -  Liver insuffisency

          -  Cancer evolutive

          -  Pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sidney Chocron, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Université de Franche-comté. France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrea Perrotti, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Université de Franche-Comté. France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Simon Rinckenbach, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Université de Franche-Comté. France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Siamak Davani, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Université de Franche-Comté. France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sidney Chocron</last_name>
    <phone>+33381533121</phone>
    <email>sidney.chocron@univ-fcomte.fr</email>
  </overall_contact>
  <reference>
    <citation>Parietti E, Pallandre JR, Deschaseaux F, Aupècle B, Durst C, Kantelip JP, Chocron S, Davani S. Presence of circulating endothelial progenitor cells and levels of stromal-derived factor-1α are associated with ascending aorta aneurysm size. Eur J Cardiothorac Surg. 2011 Jul;40(1):e6-12. doi: 10.1016/j.ejcts.2011.02.065. Epub 2011 Apr 9.</citation>
    <PMID>21481600</PMID>
  </reference>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 6, 2013</study_first_submitted>
  <study_first_submitted_qc>August 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2013</study_first_posted>
  <last_update_submitted>August 7, 2013</last_update_submitted>
  <last_update_submitted_qc>August 7, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 8, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hopital Jean Minjoz</investigator_affiliation>
    <investigator_full_name>Prof. Sidney Chocron</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Aortic aneurysm</keyword>
  <keyword>circulating endothelial progenitor cells</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

